🚀 𝗔 𝗻𝗲𝘄 𝗲𝗿𝗮 𝗶𝗻 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 𝗶𝘀 𝗵𝗲𝗿𝗲! 👀 📢 Join us for our virtual event, 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝘄𝗶𝘁𝗵 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀, 𝘄𝗵𝗲𝗿𝗲 𝘄𝗲 𝗶𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗲 𝗠𝘅𝗣® 𝗤𝘂𝗮𝗻𝘁 𝟭𝟬𝟬𝟬 – 𝘁𝗵𝗲 𝗻𝗲𝘄 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝗶𝗻 𝗾𝘂𝗮𝗻𝘁𝗶𝘁𝗮𝘁𝗶𝘃𝗲 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 that you won’t want to miss! Metabolomics already contributes to revolutionizing biomedical research, metabolic pathway analysis, and microbiome-host interactions. ❓ But how can researchers fully harness its potential? 💡 𝗠𝘅𝗣® 𝗤𝘂𝗮𝗻𝘁 𝟭𝟬𝟬𝟬 𝘀𝗲𝘁𝘀 𝗮 𝗻𝗲𝘄 𝗯𝗲𝗻𝗰𝗵𝗺𝗮𝗿𝗸 𝗶𝗻 𝗾𝘂𝗮𝗻𝘁𝗶𝘁𝗮𝘁𝗶𝘃𝗲 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 𝗽𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴. Built on 20+ years of expertise, this cutting-edge assay enables the screening of 1,200+ analytes across 49 biochemical classes – delivering instant insights with standardized workflows and AI-powered data analysis. 🎤 𝗘𝘅𝗽𝗲𝗿𝘁 𝘀𝗽𝗲𝗮𝗸𝗲𝗿𝘀 🔹 Alice Limonciel, Ph.D. – Chief Scientific Officer, biocrates life sciences 🔹 Markus Langsdorf, Ph.D. – Product Manager, biocrates life sciences 📅 April 03, 2025 | 🕔 05:00 pm CET | 💻 Virtual on ZOOM 🔥 𝗕𝗲 𝗮𝗺𝗼𝗻𝗴 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝘁𝗼 𝗲𝘅𝗽𝗹𝗼𝗿𝗲 𝗠𝘅𝗣® 𝗤𝘂𝗮𝗻𝘁 𝟭𝟬𝟬𝟬. 𝗦𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝘀𝗽𝗼𝘁 𝗻𝗼𝘄! 👉 https://zurl.co/sc20g #Metabolomics #PrecisionMedicine #Research #Innovation
biocrates life sciences ag
Biotechnologieforschung
The future of research and health
Info
biocrates is the global leader in mass spectrometry-based quantitative metabolite analysis, with kits and assays covering over 1,000+ metabolites from more than 40 metabolite classes. Our platform combines innovative technology for sample preparation, metabolite identification, and data analysis. The use of quantitative, standardized, and quality-controlled metabolomics methods guarantees robust and reproducible results that are the cornerstones of all clinical research. From just a few microliters of sample material, we can uncover the entire phenotype of an individual and answer a host of questions about systems biology.
- Website
-
https://biocrates.com
Externer Link zu biocrates life sciences ag
- Branche
- Biotechnologieforschung
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Innsbruck
- Art
- Privatunternehmen
- Gegründet
- 2002
- Spezialgebiete
- Targeted Metabolomics, Bioinformatics, Clinical Research & Clinical Diagnostics, Personalized Medicine, Cancer Research, Metabolomics Services, BioProcessing, Microbiome Research, Metabolite Quantification und Functional Microbiomics
Orte
-
Primär
Eduard-Bodem-Gasse 8
Innsbruck, AT
Beschäftigte von biocrates life sciences ag
Updates
-
🌿 Our metabolite of the month: 𝗡-𝗮𝗰𝗲𝘁𝘆𝗹-𝗮𝘀𝗽𝗮𝗿𝘁𝗶𝗰 𝗮𝗰𝗶𝗱 (𝗡𝗔𝗔)! 🌿 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝘁𝗵𝗮𝘁 𝗡𝗔𝗔, 𝗼𝗻𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗺𝗼𝘀𝘁 𝗮𝗯𝘂𝗻𝗱𝗮𝗻𝘁 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝘁𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗯𝗿𝗮𝗶𝗻, 𝘄𝗮𝘀 𝗳𝗶𝗿𝘀𝘁 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝗲𝗱 𝗶𝗻 𝟭𝟵𝟱𝟲? 🔎 Despite decades of research, its full role remains a biochemical mystery! ❓ 𝗪𝗵𝘆 𝗶𝘀 𝗡𝗔𝗔 𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁? NAA plays a key role in neuronal metabolism, osmoregulation, myelin synthesis, and lipid metabolism, though its primary function remains debated. 🦠 It is also a crucial biomarker in brain imaging, with altered levels linked to Alzheimer’s, multiple sclerosis, and psychiatric disorders. ✨ 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? 🧠 NAA is 𝗽𝗿𝗶𝗺𝗮𝗿𝗶𝗹𝘆 𝘀𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘇𝗲𝗱 𝗶𝗻 𝗻𝗲𝘂𝗿𝗼𝗻𝗮𝗹 𝗺𝗶𝘁𝗼𝗰𝗵𝗼𝗻𝗱𝗿𝗶𝗮 from acetyl-CoA and aspartic acid by the enzyme N-acetylaspartate synthetase (NAT8L). 💡Click through the carousel below for more insights. 🩸 It serves as an acetate reservoir, 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹 𝗳𝗼𝗿 𝗹𝗶𝗽𝗶𝗱 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝘀𝗺 in the brain. 📡 Its strong magnetic resonance spectroscopy (MRS) signal makes it a 𝗸𝗲𝘆 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗺𝗮𝗿𝗸𝗲𝗿. Changes in NAA levels have been associated with brain injuries, Alzheimer’s disease, multiple sclerosis, psychiatric disorders, and even cancer metabolism, making it a focus of cutting-edge research! 📖 𝗪𝗮𝗻𝘁 𝘁𝗼 𝗹𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝗡𝗔𝗔’𝘀 𝗿𝗼𝗹𝗲 𝗶𝗻 𝗻𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝘆, 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝘀𝗺, 𝗮𝗻𝗱 𝗱𝗶𝘀𝗲𝗮𝘀𝗲? Check the first comment to read the full article. #Metabolomics #Science #Loveyourmetabolites #Neurology
-
🚨 LAST CALL! 🚨 Don't miss your chance to join our virtual event 𝗛𝘂𝗺𝗮𝗻 𝗺𝗶𝗹𝗸 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 | 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗶𝗻𝘁𝗼 𝗶𝗻𝗳𝗮𝗻𝘁 𝗻𝘂𝘁𝗿𝗶𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗵𝗲𝗮𝗹𝘁𝗵! 🍼 ❓ 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝗵𝘂𝗺𝗮𝗻 𝗺𝗶𝗹𝗸 𝗰𝗼𝗻𝘁𝗮𝗶𝗻𝘀 𝗵𝘂𝗻𝗱𝗿𝗲𝗱𝘀 𝗼𝗳 𝗯𝗶𝗼𝗮𝗰𝘁𝗶𝘃𝗲 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲𝘀 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹 𝗳𝗼𝗿 𝗶𝗻𝗳𝗮𝗻𝘁 𝗵𝗲𝗮𝗹𝘁𝗵? 🔓Discover how metabolomics is unlocking its secrets and transforming our understanding of maternal and neonatal health. 📆 March 19, 2025 🕓 04:00 - 05:00 pm CET | 11:00 - 12:00 pm EST 📌 Virtual on ZOOM 🎤 Expert insights from 🔹 Teodoro Bottiglieri, Ph.D. – Target metabolomic analysis of human breast milk using the biocrates MxP Quant 500 platform 🔹 Daniela H., Ph.D. – Human milk targeted metabolomics ⏳ Only 1 day left – secure your spot now! 👉 https://zurl.co/6FOXI #Metabolomics #Health #Nutrition #Research
-
-
🍼 𝗛𝘂𝗺𝗮𝗻 𝗺𝗶𝗹𝗸 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻 𝘁𝗵𝗲 𝘀𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁! 🔬 ❓ 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝘁𝗵𝗮𝘁 𝗯𝗿𝗲𝗮𝘀𝘁 𝗺𝗶𝗹𝗸’𝘀 𝗯𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗲𝘅𝘁𝗲𝗻𝗱 𝗯𝗲𝘆𝗼𝗻𝗱 𝗶𝗻𝗳𝗮𝗻𝘁𝘀? Last September, The Economist highlighted the incredible benefits of breast milk. We are proud that biocrates technology contributed to the key study with the International Consortium for Milk Composition (#IMiC) 🔬 𝗪𝗵𝗮𝘁 𝗱𝗶𝗱 The Economist 𝗿𝗲𝗽𝗼𝗿𝘁 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝘀𝘁𝘂𝗱𝘆? Researchers analyzed 1,200 milk samples across three continents, detecting 50,000 small molecules, many previously unknown. AI-driven analysis is now linking these molecules to maternal and infant health data. 📢 𝗪𝗮𝗻𝘁 𝘁𝗼 𝗹𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲? Join our 𝗛𝘂𝗺𝗮𝗻 𝗺𝗶𝗹𝗸 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 virtual event to explore how metabolomics is transforming our understanding of breast milk’s role in infant health. 📅 March 19, 2025 🕓04:00 - 05:00 PM CET | 11:00 - 12:00 AM EST 📌 Virtual on ZOOM 🎤Speakers | Teodoro Bottiglieri, Ph.D., Daniela H., Ph.D. 𝗦𝗮𝘃𝗲 𝘆𝗼𝘂𝗿 𝘀𝗽𝗼𝘁 𝗻𝗼𝘄 👉https://zurl.co/Uhs6N 🔗 The Economist article "Breast milk’s benefits are not limited to babies": https://zurl.co/Y15uf #Metabolomics #Health #BreastMilk #Research
-
-
Metabolite History 🌟 𝗔𝘀𝘆𝗺𝗺𝗲𝘁𝗿𝗶𝗰 𝗗𝗶𝗺𝗲𝘁𝗵𝘆𝗹 𝗔𝗿𝗴𝗶𝗻𝗶𝗻𝗲 (𝗔𝗗𝗠𝗔) 🌟 📜 𝗘𝘃𝗲𝗿 𝘄𝗼𝗻𝗱𝗲𝗿𝗲𝗱 𝗵𝗼𝘄 𝗮 𝘀𝗶𝗻𝗴𝗹𝗲 𝗺𝗼𝗱𝗶𝗳𝗶𝗲𝗱 𝗮𝗺𝗶𝗻𝗼 𝗮𝗰𝗶𝗱 𝗰𝗮𝗻 𝗶𝗺𝗽𝗮𝗰𝘁 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿, 𝗻𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹, 𝗮𝗻𝗱 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵? Meet ADMA – a key regulator of nitric oxide (NO) signaling and a biomarker of endothelial dysfunction. 🔎 𝗙𝗶𝗿𝘀𝘁 𝗶𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗲𝗱 𝗶𝗻 𝗵𝘂𝗺𝗮𝗻 𝘂𝗿𝗶𝗻𝗲 𝗶𝗻 𝟭𝟵𝟳𝟬 (Kakimoto & Akazawa 1970), ADMA gained attention in 1992 when its role as an inhibitor of nitric oxide synthase (NOS) was discovered (Leone et al. 1992). This finding linked ADMA to vascular health, as NO is essential for blood vessel relaxation and function. 🔬 ADMA is generated by PRMT enzymes through arginine methylation and released during protein degradation. It competes with arginine, inhibiting NO synthesis and affecting blood flow, neurotransmission, and immunity. About 20% is excreted in urine, while 80% is degraded enzymatically by DDAH and AGTX2, maintaining vascular and metabolic balance. 🩸 𝗘𝗻𝗱𝗼𝘁𝗵𝗲𝗹𝗶𝗮𝗹 𝗵𝗲𝗮𝗹𝘁𝗵 – Elevated ADMA levels are associated with hypertension, diabetes, deep vein thrombosis, congenital heart disease, and other cardiometabolic diseases due to impaired NO production and endothelial dysfunction. 🧠 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗶𝗺𝗽𝗮𝗰𝘁 – Increased ADMA has been linked to Parkinson’s disease, stroke, and depression, likely through its effects on neuronal NOS and neurotransmission, though evidence on NOS activity in depression remains mixed. ⚖️ 𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝗿𝗼𝗹𝗲 – As a uremic toxin, ADMA clearance is vital for kidney function. Elevated levels contribute to metabolic diseases, inflammation, and oxidative stress. As research into ADMA continues, its role as a biomarker for chronic diseases underscores the importance of understanding nitric oxide regulation in health and disease. 📖 𝗪𝗮𝗻𝘁 𝘁𝗼 𝗿𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗼𝗻 𝗔𝗗𝗠𝗔? 𝗙𝗼𝗹𝗹𝗼𝘄 𝘁𝗵𝗲 𝗹𝗶𝗻𝗸 𝗶𝗻 𝘁𝗵𝗲 𝗰𝗼𝗺𝗺𝗲𝗻𝘁𝘀.👇
-
-
🚀 𝗯𝗶𝗼𝗰𝗿𝗮𝘁𝗲𝘀 𝘅 𝗣𝗹𝗮𝘁𝗼𝗺𝗶𝗰𝘀 – 𝗔 𝗴𝗮𝗺𝗲-𝗰𝗵𝗮𝗻𝗴𝗲𝗿 𝗳𝗼𝗿 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 𝗮𝗱𝗼𝗽𝘁𝗶𝗼𝗻! 💫 📢 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗻𝗲𝘄𝘀! biocrates and Platomics are joining forces to help laboratories streamline regulatory compliance and ensure reproducible, high-quality metabolomics workflows. With biocrates’ metabolomics kits now integrated into the PlatoX® platform, labs can effortlessly enhance documentation, accuracy, and efficiency. ✅ Reproducible, high-quality results ✅ Comprehensive, standardized workflow documentation ✅ Faster service with reduced operational complexity 🔍 𝗪𝗵𝗮𝘁 𝗱𝗼𝗲𝘀 𝘁𝗵𝗶𝘀 𝗺𝗲𝗮𝗻 𝗳𝗼𝗿 𝗹𝗮𝗯𝘀? The PlatoX® platform simplifies regulatory workflows, providing structured guidance from sample preparation to data analysis. 💡 𝗪𝗮𝗻𝘁 𝘁𝗼 𝗹𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲? Read the full press release here👉 https://lnkd.in/d-9eAA7M Curious about what Dr. Kriegner Albert and Moritz Seuster have to say? Check out the carousel to read their insights 🌟 #Metabolomics #DataAnalysis #Workflow #Collaboration
-
📢 Join us for the insightful virtual event 𝗛𝘂𝗺𝗮𝗻 𝗺𝗶𝗹𝗸 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 | 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗶𝗻𝘁𝗼 𝗶𝗻𝗳𝗮𝗻𝘁 𝗻𝘂𝘁𝗿𝗶𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗵𝗲𝗮𝗹𝘁𝗵! 🍼 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝗵𝘂𝗺𝗮𝗻 𝗺𝗶𝗹𝗸 𝗰𝗼𝗻𝘁𝗮𝗶𝗻𝘀 𝗵𝘂𝗻𝗱𝗿𝗲𝗱𝘀 𝗼𝗳 𝗯𝗶𝗼𝗮𝗰𝘁𝗶𝘃𝗲 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲𝘀 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹 𝗳𝗼𝗿 𝗶𝗻𝗳𝗮𝗻𝘁 𝗵𝗲𝗮𝗹𝘁𝗵❓ 💡Learn how metabolomics is unlocking its secrets to advance maternal and neonatal health and discover how cutting-edge analytical technologies transform our understanding of human milk composition and its impact on early-life nutrition. 📆 March 19, 2025 🕓 04:00 - 05:00 pm CET | 11:00 - 12:00 pm EST 📌 Virtual on ZOOM 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀 🎙️Teodoro Bottiglieri, Ph.D. – Target metabolomic analysis of human breast milk using the biocrates MxP Quant 500 platform 🎙️ Daniela H., Ph.D. – Human milk targeted metabolomics Register now 👉 https://zurl.co/6FOXI We look forward to connecting and sharing valuable insights with you! 🔗 #Metabolomics #Health #Nutrition #Research
-
-
💡 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝘄𝗶𝘁𝗵 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 – 𝗔 𝟱-𝗽𝗮𝗿𝘁 𝗯𝗹𝗼𝗴 𝘀𝗲𝗿𝗶𝗲𝘀! 💻 Preventive medicine is evolving, and metabolomics is one of the key drivers of this transformation! In the first instalment of our new blog series, Alice Limonciel 𝗲𝘅𝗽𝗹𝗼𝗿𝗲𝘀 𝗵𝗼𝘄 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 𝗳𝗶𝘁𝘀 𝗶𝗻𝘁𝗼 𝘁𝗵𝗲 𝟱𝗣 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 – shifting healthcare from a reactive model to a proactive, personalized, and population-driven approach. Why does this matter❓ Because 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 𝗰𝗮𝗻 𝗱𝗲𝘁𝗲𝗰𝘁 𝗰𝗵𝗮𝗻𝗴𝗲𝘀 𝗶𝗻 𝗼𝘂𝗿 𝗵𝗲𝗮𝗹𝘁𝗵 𝗯𝗲𝗳𝗼𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝘀, enabling early interventions through diet, microbiome modulation, and metabolic risk assessments. 🔎 In this blog, discover 🔹How metabolomics supports 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝘃𝗲 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 🔹The role of diet and microbiome-derived metabolites in health 🔹 Why 𝗺𝘂𝗹𝘁𝗶𝗼𝗺𝗶𝗰𝘀 is key to an actual healthcare revolution 🔗 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗵𝗲𝗿𝗲 👉 https://zurl.co/285c1 🔔 𝗦𝘁𝗮𝘆 𝘁𝘂𝗻𝗲𝗱 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝗯𝗹𝗼𝗴𝘀 𝗶𝗻 𝗼𝘂𝗿 𝘀𝗲𝗿𝗶𝗲𝘀 as Alice Limonciel continues to explore the power of 5P medicine! #Metabolomics #Medicine #Blog #HealthcareInnovation
-
-
🌿 Our metabolite of the month: 𝗖𝗶𝘁𝗿𝗶𝗰 𝗮𝗰𝗶𝗱! 🌿 Did you know that citric acid was 𝗳𝗶𝗿𝘀𝘁 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝗲𝗱 𝗶𝗻 𝟭𝟳𝟴𝟰 𝗯𝘆 𝗖𝗮𝗿𝗹 𝗪𝗶𝗹𝗵𝗲𝗹𝗺 𝗦𝗰𝗵𝗲𝗲𝗹𝗲 – over 240 years ago? 🔎 This essential metabolite plays a pivotal role in energy production, calcium signaling, and metabolic regulation across all aerobic organisms. 𝗪𝗵𝘆 𝗶𝘀 𝗰𝗶𝘁𝗿𝗶𝗰 𝗮𝗰𝗶𝗱 𝘀𝗼 𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁❓ Citric acid drives energy production in the TCA cycle, supports lipid metabolism, amino acid synthesis, and pH balance. It also plays a role in kidney stone prevention, bone health, cancer metabolism, and immune response. 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? 🍊 Citric acid is abundant in citrus fruits and other fruits and vegetables. 🦴 90% of your body’s citrate is stored in bone tissue. 🧠 New research suggests citrate may act as a potential biomarker for Alzheimer’s and a therapeutic target for cancer. 🦠 Citric acid supplementation may support gut health by promoting beneficial bacteria and strengthening the intestinal barrier, as observed in experimental studies in mice. From food and beverages to pharmaceuticals, citric acid is the most widely consumed organic acid worldwide. Its remarkable versatility continues to open new doors in health, industry, and cutting-edge metabolomics research. Want to discover more about citric acid's impact on metabolism, microbiome interactions, and disease mechanisms? 𝗖𝗵𝗲𝗰𝗸 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝗰𝗼𝗺𝗺𝗲𝗻𝘁 𝗳𝗼𝗿 𝗳𝘂𝗿𝘁𝗵𝗲𝗿 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀!💡 #Metabolomics #Science #Loveyourmetabolites #Microbiome
-
-
LAST CALL! Don’t miss our free virtual event 𝗠𝘂𝗹𝘁𝗶𝗼𝗺𝗶𝗰𝘀 – 𝗧𝗵𝗲 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗼𝗳 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄 𝗮𝘁 𝘆𝗼𝘂𝗿 𝗳𝗶𝗻𝗴𝗲𝗿𝘁𝗶𝗽𝘀 🚨 🔍 𝗖𝘂𝗿𝗶𝗼𝘂𝘀 𝗵𝗼𝘄 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 𝗵𝗲𝗹𝗽𝘀 𝘂𝗻𝗹𝗼𝗰𝗸 𝗻𝗲𝘄 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗺𝘂𝗹𝘁𝗶𝗼𝗺𝗶𝗰𝘀 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵? Join us to explore how multiomics advances biomarker discovery, disease research, and precision medicine and why metabolomics is key in integrating these insights for clinical and research applications. 💡 Speakers 🎤 🔹Ass. Prof. Spencer Rosario – Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer 🔹Alice Limonciel, Ph.D. – Multiomics for 5P medicine 🔹Juozas Gordevicius, Ph.D. – Unraveling disease mechanics through multi-omic integration: Insights from metabolomics and beyond 📆 February 25, 2025 🕓 04:00 - 05:30 PM CET 💻 Virtual on ZOOM 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄 👉https://lnkd.in/dhZJD4AH We're looking forward to connecting with you! 🔗 #Multiomics #Metabolomics #PrecisionMedicine #HealthcareInnovation
-